Viewing Study NCT04019704

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:19 PM
Ignite Modification Date: 2026-01-24 @ 7:37 AM
Study NCT ID: NCT04019704
Status: COMPLETED
Last Update Posted: 2022-10-12
First Post: 2019-07-11
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Trial of AXS-05 in Patients With Major Depressive Disorder
Sponsor: Axsome Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Depression View
None Major Depressive Disorder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Depressive Disorder View
None Depressive Disorder, Major View
None Bupropion View
None Dextromethorphan View
None MDD View
None Dopamine Reuptake Inhibitor View
None AXS-05 View
None NMDA Receptor Antagonist View
None Central Nervous System View
None CNS View
None Sigma-1 Receptor Agonist View
None Nicotinic Acetylcholine Receptor Antagonist View
None Norepinephrine Reuptake Inhibitor View
None Glutamate Modulator View
None Axsome Therapeutics View
None GEMINI View
None Serotonin Reuptake Inhibitor View